Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1985-6-7
|
pubmed:abstractText |
The antiviral substance PFA (trisodium phosphonoformate) was administered I.V. and P.O. to six young female Beagle dogs, and to white New Zealand rabbits using a randomized crossover design. The pharmacokinetics of PFA was determined from the I.V. concentration-time data by polyexponential curve fitting and by a compartment model independent analysis. In dogs the I.V. data were best fit to three exponential terms. The terminal half-life ranged from 2.6 to 7.9 hours (mean 4.03 h +/- 2.04 S.D.). The mean volumes of distribution for the central compartment, Vc, at steady state, Vss and during the terminal phase, Vz, were 0.15, 0.65 and 1.32 L/kg, respectively. The two methods for generation of pharmacokinetic parameters resulted in practically identical values. After extravascular administration, the concentration-time data were subjected to compartment model independent analysis. The mean absolute bioavailability was 10% after P.O. administration. In rabbits, 11 out of 12 I.V. data sets were best fit to two exponential terms; one set was best fit to 3 exponential terms. The terminal half-life ranged from 1.47 to 4.15 hours (mean 2.18 h +/- 0.87 S.D.). The mean volumes of distribution for Vc, Vss and Vz were 0.32, 0.45 and 0.96 L/kg, respectively. After P.O. dosing the t 1/2 was about 4.4 h and the apparent volume of distribution about 1.2 L/kg. The mean absolute bioavailability after P.O. administration was 95%. The difference in P.O. bioavailability between dog and rabbit may be due to intragastric pH differences between the two species.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0379-0355
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
41-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3157841-Administration, Oral,
pubmed-meshheading:3157841-Animals,
pubmed-meshheading:3157841-Antiviral Agents,
pubmed-meshheading:3157841-Biological Availability,
pubmed-meshheading:3157841-Dogs,
pubmed-meshheading:3157841-Female,
pubmed-meshheading:3157841-Foscarnet,
pubmed-meshheading:3157841-Injections, Intravenous,
pubmed-meshheading:3157841-Kinetics,
pubmed-meshheading:3157841-Models, Biological,
pubmed-meshheading:3157841-Organophosphorus Compounds,
pubmed-meshheading:3157841-Phosphonoacetic Acid,
pubmed-meshheading:3157841-Rabbits,
pubmed-meshheading:3157841-Species Specificity
|
pubmed:year |
1985
|
pubmed:articleTitle |
Pharmacokinetics of PFA (trisodium phosphonoformate) after i.v. and p.o. administration to beagle dogs and rabbits.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|